Literature DB >> 20200439

Androgen receptor CAG repeat length and risk of biliary tract cancer and stones.

Tamra E Meyer1, Thomas G O'Brien, Gabriella Andreotti, Kai Yu, Qizhai Li, Yu-Tang Gao, Asif Rashid, Ming-Chang Shen, Bing-Sheng Wang, Tian-Quan Han, Bai-He Zhang, Shelley Niwa, Joseph F Fraumeni, Ann W Hsing.   

Abstract

Biliary tract cancers, encompassing cancers of the gallbladder, extrahepatic bile ducts, and ampulla of Vater, are rare but highly fatal. Gallstones represent the major risk factor for biliary tract cancer, and share with gallbladder cancer a female predominance and an association with reproductive factors and obesity. Although estrogens have been implicated in earlier studies of gallbladder cancer, there are no data on the role of androgens. Because intracellular androgen activity is mediated through the androgen receptor (AR), we examined associations between AR CAG repeat length [(CAG)(n)] and the risk of biliary tract cancers and stones in a population-based study of 331 incident cancer cases, 837 gallstone cases, and 750 controls from Shanghai, China, where the incidence rates for biliary tract cancer are rising sharply. Men with (CAG)(n) >24 had a significant 2-fold risk of gallbladder cancer [odds ratio (OR), 2.00; 95% confidence interval (CI), 1.07-3.73], relative to those with (CAG)(n) < or = 22. In contrast, women with (CAG)(n) >24 had reduced gallbladder cancer risk (OR, 0.69; 95% CI, 0.43-1.09) relative to those with (CAG)(n) < or = 22; P interaction sex = 0.01, which was most pronounced for women ages 68 to 74 (OR, 0.48; 95% CI, 0.25-0.93; P interaction age = 0.02). No associations were found for bile duct cancer or gallstones. Reasons for the heterogeneity of genetic effects by gender and age are unclear but may reflect an interplay between AR and the levels of androgen as well as estrogen in men and older women. Further studies are needed to confirm these findings and clarify the mechanisms involved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20200439      PMCID: PMC2837546          DOI: 10.1158/1055-9965.EPI-09-0973

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  37 in total

1.  The CAG repeat polymorphism in the AR gene affects high density lipoprotein cholesterol and arterial vasoreactivity.

Authors:  M Zitzmann; M Brune; B Kornmann; J Gromoll; S von Eckardstein; A von Eckardstein; E Nieschlag
Journal:  J Clin Endocrinol Metab       Date:  2001-10       Impact factor: 5.958

2.  Automated fragment analysis method for determining androgen receptor CAG repeat length.

Authors:  D W Boorman; Y Guo; K Visvanathan; K Helzlsouer; T G O'Brien
Journal:  Biotechniques       Date:  2002-07       Impact factor: 1.993

Review 3.  Androgen receptor CAG repeats and prostate cancer.

Authors:  Kevin A Nelson; John S Witte
Journal:  Am J Epidemiol       Date:  2002-05-15       Impact factor: 4.897

4.  The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.

Authors:  Christopher A Haiman; Myles Brown; Susan E Hankinson; Donna Spiegelman; Graham A Colditz; Walter C Willett; Philip W Kantoff; David J Hunter
Journal:  Cancer Res       Date:  2002-02-15       Impact factor: 12.701

5.  Prostate-specific antigen, testosterone, sex-hormone binding globulin and androgen receptor CAG repeat polymorphisms in subfertile and normal men.

Authors:  A Mifsud; A T Choon; D Fang; E L Yong
Journal:  Mol Hum Reprod       Date:  2001-11       Impact factor: 4.025

Review 6.  Mechanisms in tissue-specific regulation of estrogen biosynthesis in humans.

Authors:  Amrita Kamat; Margaret M Hinshelwood; Barbara A Murry; Carole R Mendelson
Journal:  Trends Endocrinol Metab       Date:  2002-04       Impact factor: 12.015

7.  Lack of influence of the androgen receptor gene CAG-repeat polymorphism on sex steroid status and bone metabolism in elderly men.

Authors:  I Van Pottelbergh; S Lumbroso; S Goemaere; C Sultan; J M Kaufman
Journal:  Clin Endocrinol (Oxf)       Date:  2001-11       Impact factor: 3.478

Review 8.  The CAG repeat polymorphism within the androgen receptor gene and maleness.

Authors:  Michael Zitzmann; Eberhard Nieschlag
Journal:  Int J Androl       Date:  2003-04

Review 9.  The androgen receptor CAG repeat: a modifier of carcinogenesis?

Authors:  Paola Ferro; Maria G Catalano; Raffaella Dell'Eva; Nicoletta Fortunati; Ulrich Pfeffer
Journal:  Mol Cell Endocrinol       Date:  2002-07-31       Impact factor: 4.102

Review 10.  The role of androgens and polymorphisms in the androgen receptor in the epidemiology of breast cancer.

Authors:  Elizabeth O Lillie; Leslie Bernstein; Giske Ursin
Journal:  Breast Cancer Res       Date:  2003-04-02       Impact factor: 6.466

View more
  4 in total

Review 1.  Candidate gene studies in gallbladder cancer: a systematic review and meta-analysis.

Authors:  Kshitij Srivastava; Anvesha Srivastava; Kiran Lata Sharma; Balraj Mittal
Journal:  Mutat Res       Date:  2011-06-25       Impact factor: 2.433

2.  PXR prevents cholesterol gallstone disease by regulating biosynthesis and transport of bile salts.

Authors:  Jinhan He; Shigeru Nishida; Meishu Xu; Makoto Makishima; Wen Xie
Journal:  Gastroenterology       Date:  2011-02-24       Impact factor: 22.682

3.  Expression of procaspase 3 and activated caspase 3 and its relevance in hormone-responsive gallbladder carcinoma chemotherapy.

Authors:  Sanjeev Kumar Maurya; Mallika Tewari; Bechan Sharma; Hari Shanker Shukla
Journal:  Korean J Intern Med       Date:  2013-08-14       Impact factor: 2.884

Review 4.  Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update.

Authors:  Aarti Sharma; Kiran Lata Sharma; Annapurna Gupta; Alka Yadav; Ashok Kumar
Journal:  World J Gastroenterol       Date:  2017-06-14       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.